OncRef

Clinical Trial: NCT05969314

To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer

Status:

ACTIVE NOT RECRUITING

Phase:

Phase 1

Lead Sponsor:Tata Memorial Hospital
Information Provided By:Tata Memorial Hospital
Last Update Posted:2026-10-02

Study Overview

Brief Summary

Phase 1 study to assess the pharmacokinetic availability and safety and tolerability profile of one such ayurvedic preparation which contains 5 mg THC:CBD 1:1 preparation. Other than the PK profile, we will also be studying its effect on gene expression profiling of the breast and head neck oral cavity squamous cell carcinoma tissue.

Official Title

Phase I Study of Safety and Feasibility of Ayurvedic Oral Cannabis Preparation in the Peri-operative Period in Breast and Oral Cavity Squamous Cell Cancer

Conditions

Breast Cancer, Oral Cancer

Intervention / Treatment

  • Drug: Cannabis capsules

Other Study ID Numbers

  • TMH Project No. 3386
  • CTRI/2020/06/020649

Start Date (Actual)

2022-06-08

Primary Completion Date (Estimated)

2026-12-30

Study Completion Date (Estimated)

2026-12-30

Enrollment (Actual)

12

Study Type

Interventional

Phase

Phase 1